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The diagnosis of uremia-associated effusion is one of exclusion. A patient with an unexplained chronic pleural
exudate, which cleared with dialysis, is reported. The differential diagnosis of pleural effusions in patients with
chronic kidney disease and the management of uremic pleuritis is briefly discussed.
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A
48-year-old man was evaluated for a new pleural
effusion. He had hypertension and a 2-year
history of type 2 diabetes mellitus. Four months
earlier, he had developed overt proteinuria, which was
followed by a percutaneous kidney biopsy that demon-
strated diabetic nephropathy. At that time, laboratory
studies revealed a serum creatinine level of 1.5 mg/dL,
blood urea nitrogen of 39 mg/dL, and an estimated
glomerular filtration rate using the Modification of Diet
in Renal Disease (MDRD) equation of 51 mL/min/
1.73 m2. No pleural effusions were detected on a chest
radiograph. Medications were metformin, insulin glar-
gine, furosemide, and valsartan.
Most recently, the patient was hospitalized for a
pulsatile mass on the right inner thigh with an associated
ipsilateral lower extremity edema. On physical examina-
tion, the patient was afebrile, and decreased breath
sounds and dullness to percussion on the right chest
was noted. There was no elevation in jugular venous
pressure, and cardiac examination was unremarkable.
Chest radiograph revealed a right-sided pleural effusion
occupying nearly half of the hemithorax (Fig. 1),
although the patient had no respiratory complaints.
Results of laboratory studies showed a serum creati-
nine level of 2.88 mg/dL, blood urea nitrogen of 58 mg/
dL, an estimated glomerular filtration rate of 20 mL/min/
1.73 m2, a leukocyte count of 8.7109/L, and a hemo-
globin level of 8.5 mg/dL. Pleural fluid analysis showed:
erythrocyte count 4,100/mL, leukocytes 1,064/mL (80%
lymphocytes), glucose 104 mg/dL, protein 3.2 g/dL
(serum 6 g/dL), lactate dehydrogenase 328 U/L (serum
324 U/L; upper normal limit for serum 480 U/L),
cholesterol 66 mg/dL, albumin 1.2 g/dL (serum 2.3 g/
dL), pH 7.43, adenosine deaminase 17.8 U/L, negative
bacterial and mycobacterial cultures, and no malignant
cells. An angio-CT with preventive interventions for
contrast-induced nephropathy (i.e., isotonic intravenous
fluids, N-acetylcysteine, and sodium bicarbonate) ruled
out pulmonary embolism and displayed a large loculated
right-sided pleural effusion. Kidney function tests did not
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Fig. 1. Initial chest radiograph (A) and CT (B) showing a large loculated right-sided pleural effusion.
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change after CT imaging. Echocardiography showed left
ventricular hypertrophy, and abdominal CT was not
contributory. An ultrasonography of the legs detected a
6-cm superficial right femoral artery pseudoaneurism
compressing the deep venous system.
Given the possibility of a non-specific pleuritis (e.g.,
viral pleuritis) and the contraindication for the use of
non-steroidal anti-inflammatory drugs, an empirical
tapering course of prednisone (initial dose of 30-mg
daily) was instituted. The pleural effusion remained
unchanged during follow-up visits at 6 weeks intervals.
A thoracoscopic pleural biopsy was then planned, but
soon after (4 months from the start of corticosteroid
therapy), the patient developed signs of volume overload
and deterioration of the renal function (blood urea
nitrogen 55 mg/dL, creatinine 5.23 mg/dL, glomerular
filtration rate 12.6 mL/min/1.73 m2). Consequently,
corticosteroids were stopped and hemodialysis was
promptly initiated. Later, the effusion gradually cleared
and 4 months later virtually disappeared (Fig. 2), thus
confirming its relationship with a uremic state. The Kt/V,
a way of measuring hemodialysis adequacy, has always
been above 1.4, as recommended by the current guide-
lines. The pseudoaneurism was subsequently repaired
using endovascular techniques.
Discussion
Patients with end-stage renal disease may develop pleural
effusions due to many causes, including volume overload,
heart failure, peritoneal dialysis (in all such cases the fluid
is a transudate), infection, pulmonary embolism, malig-
nancy, uremia, or following long-term hemodialysis.
Uremic pleuritis results from inflammation of the
visceral and parietal pleural membranes and its patho-
genesis is poorly understood (1). The incidence of
fibrinous pleuritis, whether or not associated with pleural
effusion, is reported to be 2057% in patients who died of
uremia (2). Half the patients are asymptomatic, while the
remainder have fever, pleuritic chest pain, dyspnea, or
non-productive cough (2). A close relationship between
the degree of uremia and the occurrence of pleural
effusions has not been found (3). Effusions are unilateral
in 80% of patients and may be large. The pleural fluid is
typically a serous or serosanguineous exudate with a
predominance of either lymphocytes or neutrophils (4).
Pleural biopsy, when performed, shows chronic fibrinous
pleuritis. One third of patients have a concomitant
pericardial effusion (4).
Uremic pleuritis, which is a diagnosis of exclusion, is
strongly supported by the resolution of the effusion
within several weeks or months of continued dialysis.
However, in about 20% of cases the pleuritis persists,
recurs or occasionally progresses to restrictive ventilatory
dysfunction that needs decortication (1). A few anecdotal
cases of refractory uremic pleuritis have improved with
corticosteroids (5).
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Fig. 2. Gradual resolution of the pleural effusion, 1 month (A) and 4 months (B) after initiation of hemodialysis.
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